NASDAQ:MREO | Profit Breakdown | Mereo BioPharma Group plc

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2022-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$0.00-$7.03M-$7.01M-$7.01M
2026-03-31-$8.77M-$6.72M-$6.72M
2025-12-31$0.00-$8.39M-$7.35M-$7.35M
2025-09-30$0.00-$10.02M-$7.02M-$7.02M
2025-06-30$500,000.00-$10.5M-$14.62M-$14.62M
2025-03-31-$11.2M-$12.89M-$12.89M
2024-12-31$0.00-$15.28M-$7.05M-$7.05M
2024-09-30$0.00-$9.37M-$15M-$15M
2024-06-30$0.00-$12.81M-$12.26M-$12.26M
2024-03-31$0.00-$9.9M-$8.95M-$8.95M
2023-12-31$1M-$7.13M-$9.64M-$9.11M
2023-09-30$0.00-$9.07M-$6.53M-$6.53M
2023-06-30$9M-$811,000.00-$1.75M-$1.75M
2023-03-31$0.00-$11.41M-$12.08M-$12.08M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$500,000.00-$40.11M-$41.88M-$41.88M
2024-12-31$0.00-$47.36M-$43.25M-$43.25M
2023-12-31$10M-$28.42M-$30M-$29.47M
2022-12-31$0.00-$54.43M-$42.94M-$42.22M